While lawmakers are back in their districts during Congress' recess, AdvaMed is running local ads aimed at major congressional leaders to ensure they continue to prioritize repealing the 2.3% medical device excise tax.
After Republican senators failed to kill the medical device excise tax with their Affordable Care Act (ACA) repeal efforts, Advamed says it is running local ads around the country to keep pressure on congressional leaders to prevent the tax from coming back in 2018.
The largest medical device lobby group says it is running ads in 15 states between Aug. 14 and Labor Day...
The US House of Representatives passes legislation requiring manufacturers of non-flushable wet wipes to label products as ‘non-flushable," a move endorsed by the Personal Care Products Council.
Paul Campbell, chief regulatory officer at HealthAI, emphasizes existing regulations for AI in healthcare should not be overlooked as new regulations are developed.
The US FDA needs to know who wants a seat at the MDUFA negotiations table before discussions can begin. The agency is asking stakeholders to let it know if they plan to participate in the periodic consultation meetings before July 28.
The US FDA has given up on its effort to regulate lab-developed tests as medical devices, at least for now. The agency will not appeal a decision from the Eastern District of Texas that tossed out the FDA’s final rule, leaving the agency with few cards.
